{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:37:55Z","timestamp":1778225875974,"version":"3.51.4"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01 EY024972"],"award-info":[{"award-number":["R01 EY024972"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30 EY025585"],"award-info":[{"award-number":["P30 EY025585"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["RPB1801"],"award-info":[{"award-number":["RPB1801"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006792","name":"Hartwell Foundation","doi-asserted-by":"publisher","award":["HWF06092015"],"award-info":[{"award-number":["HWF06092015"]}],"id":[{"id":"10.13039\/100006792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"DOI":"10.3389\/fcell.2020.00488","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T05:22:19Z","timestamp":1592889739000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Rank Order of Small Molecule Induced Hypoxiamimesis to Prevent Retinopathy of Prematurity"],"prefix":"10.3389","volume":"8","author":[{"given":"George","family":"Hoppe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youstina","family":"Bolok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"McCollum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan E.","family":"Sears","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1056\/nejm199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.","volume":"331","author":"Aiello","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"10457","DOI":"10.1073\/pnas.92.23.10457","article-title":"Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.","volume":"92","author":"Aiello","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/nm1095-1024","article-title":"Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity.","volume":"1","author":"Alon","year":"1995","journal-title":"Nat. Med."},{"key":"B4","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-20278-4","article-title":"Targeted Knockdown of Overexpressed VEGFA or VEGF164 in Muller cells maintains retinal function by triggering different signaling mechanisms.","volume":"8","author":"Becker","year":"2018","journal-title":"Sci. Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1542\/peds.2007-0117","article-title":"Pulse oxygen saturation levels and arterial oxygen tension values in newborns receiving oxygen therapy in the neonatal intensive care unit: is 85% to 93% an acceptable range?","volume":"121","author":"Castillo","year":"2008","journal-title":"Pediatrics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/nejmoa1901713","article-title":"Roxadustat treatment for anemia in patients undergoing long-term dialysis.","volume":"381","author":"Chen","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/nprot.2009.187","article-title":"Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis.","volume":"4","author":"Connor","year":"2009","journal-title":"Nat. Protoc."},{"key":"B8","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.bbrc.2005.08.140","article-title":"Dioxygenases as O2-dependent regulators of the hypoxic response pathway.","volume":"338","author":"Dann","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/s0092-8674(01)00507-4","article-title":"C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.","volume":"107","author":"Epstein","year":"2001","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1128\/mcb.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.","volume":"16","author":"Forsythe","year":"1996","journal-title":"Mol. Cell Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.blre.2012.12.003","article-title":"Regulation of erythropoiesis by hypoxia-inducible factors.","volume":"27","author":"Haase","year":"2013","journal-title":"Blood Rev."},{"key":"B12","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1056\/NEJMra1208129","article-title":"Mechanisms and management of retinopathy of prematurity\u2217.","volume":"367","author":"Hartnett","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"26351","DOI":"10.1074\/jbc.c200273200","article-title":"Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family.","volume":"277","author":"Hewitson","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.bbrc.2005.08.193","article-title":"Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases.","volume":"338","author":"Hirota","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1016\/j.ajpath.2014.02.017","article-title":"Inducing a Visceral organ to protect a peripheral capillary bed: stabilizing Hepatic HIF-1alpha Prevents Oxygen-Induced Retinopathy.","volume":"184","author":"Hoppe","year":"2014","journal-title":"Am. J. Pathol."},{"key":"B16","doi-asserted-by":"crossref","first-page":"E2516","DOI":"10.1073\/pnas.1523005113","article-title":"Comparative systems pharmacology of HIF stabilization in the prevention of retinopathy of prematurity.","volume":"113","author":"Hoppe","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.kint.2018.08.043","article-title":"Generation of renal Epo-producing cell lines by conditional gene tagging reveals rapid HIF-2 driven Epo kinetics, cell autonomous feedback regulation, and a telocyte phenotype.","volume":"95","author":"Imeri","year":"2019","journal-title":"Kidney Int."},{"key":"B18","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.bbrc.2005.08.165","article-title":"The von Hippel-Lindau protein. HIF hydroxylation, and oxygen sensing.","volume":"338","author":"Kaelin","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1182\/blood-2010-02-270322","article-title":"Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia.","volume":"116","author":"Kapitsinou","year":"2010","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nrneph.2015.82","article-title":"Anaemia in kidney disease: harnessing hypoxia responses for therapy.","volume":"11","author":"Koury","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"B22","first-page":"864","article-title":"In vitro characterization of a spontaneously immortalized human Muller cell line (MIO-M1).","volume":"43","author":"Limb","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1159\/000464476","article-title":"Clinical trial of vadadustat in patients with anemia secondary to stage 3 or 4 Chronic Kidney Disease.","volume":"45","author":"Martin","year":"2017","journal-title":"Am. J. Nephrol."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1126\/science.1192811","article-title":"Reactivation of hepatic EPO synthesis in mice after PHD loss.","volume":"329","author":"Minamishima","year":"2010","journal-title":"Science"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1016\/s0960-894x(03)00539-0","article-title":"2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.","volume":"13","author":"Mole","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1056\/nejmoa0911781","article-title":"Target ranges of oxygen saturation in extremely preterm infants.","volume":"362","author":"Network","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.03.037","article-title":"EGLN1 Inhibition and Rerouting of alpha-Ketoglutarate Suffice for Remote Ischemic Protection.","volume":"165","author":"Olenchock","year":"2016","journal-title":"Cell"},{"key":"B28","first-page":"94","article-title":"Current concepts of oxygen management in retinopathy of prematurity.","volume":"9","author":"Owen","year":"2014","journal-title":"J. Ophthalmic Vis. Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.siny.2010.05.006","article-title":"Hypoxia-inducible factor (HIF) and HIF-stabilizing agents in neonatal care.","volume":"15","author":"Park","year":"2010","journal-title":"Semin. Fetal Neonatal. Med."},{"key":"B30","first-page":"623","article-title":"The rat as an animal model for retinopathy of prematurity.","volume":"314","author":"Penn","year":"1989","journal-title":"Prog. Clin. Biol. Res."},{"key":"B31","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archopht.1996.01100140419009","article-title":"Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.","volume":"114","author":"Pierce","year":"1996","journal-title":"Arch. Ophthalmol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"9369","DOI":"10.1021\/jm400386j","article-title":"Inhibition of hypoxia-inducible factor prolyl hydroxylase domain oxygen sensors: tricking the body into mounting orchestrated survival and repair responses.","volume":"56","author":"Rabinowitz","year":"2013","journal-title":"J. Med. Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1073\/pnas.0509459103","article-title":"Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production.","volume":"103","author":"Safran","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1053\/j.ackd.2019.04.004","article-title":"Hypoxia-Inducible factor activators in Renal Anemia: current clinical experience.","volume":"26","author":"Sanghani","year":"2019","journal-title":"Adv. Chronic Kidney Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.bbrc.2005.08.111","article-title":"Signalling hypoxia by HIF hydroxylases.","volume":"338","author":"Schofield","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B36","doi-asserted-by":"publisher","first-page":"19898","DOI":"10.1073\/pnas.0805817105","article-title":"Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy.","volume":"105","author":"Sears","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B37","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/s0959-437x(98)80016-6","article-title":"Hypoxia-inducible factor 1: master regulator of O2 homeostasis.","volume":"8","author":"Semenza","year":"1998","journal-title":"Curr. Opin. Genet. Dev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.1073\/pnas.88.13.5680","article-title":"Hypoxia-inducible nuclear factors bind to an enhancer element located 3\u2032 to the human erythropoietin gene.","volume":"88","author":"Semenza","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B39","doi-asserted-by":"publisher","first-page":"5447","DOI":"10.1128\/mcb.12.12.5447","article-title":"A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation.","volume":"12","author":"Semenza","year":"1992","journal-title":"Mol. Cell. Biol."},{"key":"B40","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.129398","article-title":"Serine and 1-carbon metabolism are required for HIF-mediated protection against retinopathy of prematurity.","volume":"4","author":"Singh","year":"2019","journal-title":"JCI Insight"},{"key":"B41","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1167\/iovs.18-24120","article-title":"3-Hydroxypyruvate Destabilizes Hypoxia inducible factor and induces angiostasis.","volume":"59","author":"Singh","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B42","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15066-6","article-title":"Hyperoxia induces glutamine-fuelled anaplerosis in retinal Muller cells.","volume":"11","author":"Singh","year":"2020","journal-title":"Nat. Commun."},{"key":"B43","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse.","volume":"35","author":"Smith","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B44","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1167\/iovs.13-12171","article-title":"Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy in the rat 50\/10 model.","volume":"54","author":"Trichonas","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1002\/glia.20997","article-title":"Astrocyte hypoxic response is essential for pathological but not developmental angiogenesis of the retina.","volume":"58","author":"Weidemann","year":"2010","journal-title":"Glia"},{"key":"B46","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.97585","article-title":"Fully automated, deep learning segmentation of oxygen-induced retinopathy images.","volume":"2","author":"Xiao","year":"2017","journal-title":"JCI Insight"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2020.00488\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T05:22:26Z","timestamp":1592889746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2020.00488\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,23]]},"references-count":46,"alternative-id":["10.3389\/fcell.2020.00488"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2020.00488","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,23]]},"article-number":"488"}}